Brigatinib from Japan
Brigatinib is an ALK inhibitor for lung cancer treatment. This macrocyclic aromatic nitrogen-heterocycle drug substance imports under HTS 2933.99.75.00.
Duty Rate — Japan → United States
12.5%
Rate breakdown
9903.05.4912.5%Section 301 (forced labor) — Japan (col1 rate < 12.5 percent): MFN < 12.5% → total duty capped at 12.5%
Import Tips
• GMP compliance audit trail required from API manufacturer
• Residual solvent analysis per ICH Q3C mandatory for entry
• Avoid declaring as 'new chemical entity' after FDA approval